Cartesian Therapeutics, Inc. RNAC NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score

56/100

3/7 Pass

SharesGrow Intrinsic Value

Il y a eu 50 transactions d'initiés récentes enregistrées pour Cartesian Therapeutics, Inc. (RNAC), dont 25 achats et 21 ventes. Le total des achats d'initiés s'élève à $5.23M et le total des ventes d'initiés à $967.74K.

Les initiés notables ayant une activité récente comprennent Kalayoglu Murat, Hoge Elizabeth, Singer Michael. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — RNAC

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2026-04-02	Kalayoglu Murat	10 Percent Owner	Exercice d'Options (Vente)	22,740	-	-	33,662
2026-04-02	Hoge Elizabeth	10 Percent Owner	Exercice d'Options (Vente)	22,740	-	-	33,662
2026-03-13	Singer Michael	Director	Don (Donné)	6,555	-	-	49,578
2026-01-06	Brunn Carsten	President and CEO	Vente Informative	23,766	$6.82	$162.08K	323,530
2026-01-06	Davis Blaine	Chief Financial Officer	Vente Informative	10,591	$6.82	$72.23K	121,220
2026-01-06	Miljkovic Milos	Chief Medical Officer	Vente Informative	3,573	$6.82	$24.37K	58,820
2026-01-02	Springer Timothy A	10 Percent Owner	Attribution de RSU	7,800	$6.76	$52.73K	7,800
2026-01-02	Zenner Patrick J	Director	Attribution de RSU	7,800	$6.76	$52.73K	7,800
2026-01-02	Barabe Timothy C	Director	Attribution de RSU	7,800	$6.76	$52.73K	7,800
2026-01-02	Desilva Nishan M	Director	Attribution de RSU	7,800	$6.76	$52.73K	7,800
2026-01-02	Brunn Carsten	President and CEO	Attribution de RSU	143,200	-	-	347,296
2026-01-02	Malik Kemal	Director	Attribution de RSU	7,800	$6.76	$52.73K	7,800
2026-01-02	Davis Blaine	Chief Financial Officer	Attribution de RSU	109,000	$6.76	$736.84K	109,000
2026-01-02	Kalayoglu Murat	10 Percent Owner	Attribution de RSU	7,800	$6.76	$52.73K	7,800
2026-01-02	Singer Michael	Director	Attribution de RSU	7,800	$6.76	$52.73K	7,800
2026-01-02	Miljkovic Milos	Chief Medical Officer	Attribution de RSU	27,000	-	-	62,393
2026-01-02	English Emily	Chief Operations Officer	Attribution de RSU	71,000	$6.76	$479.96K	71,000
2026-01-02	Seymour June Ann	Chief Accounting Officer	Attribution de RSU	6,500	-	-	6,500
2025-12-30	English Emily	Chief Operations Officer	Exercice d'Options (Vente)	7,500	$3.30	$24.75K	19,369
2025-12-16	Bot Adrian Ion	Director	Inconnu	-	-	-	-
2025-12-16	Bot Adrian Ion	Director	Attribution de RSU	5,800	-	-	5,800
2025-12-04	Barabe Timothy C	Director	Achat Informatif	30,000	$6.86	$205.8K	54,366
2025-11-28	English Emily	Chief Operations Officer	Exercice d'Options (Vente)	7,500	$3.30	$24.75K	26,869
2025-11-18	Singer Michael	Director	Don (Donné)	20,000	-	-	53,533
2025-10-27	Seymour June Ann	Officer	Inconnu	-	-	-	-
2025-10-27	Seymour June Ann	Chief Accounting Officer	Attribution de RSU	50,000	$8.85	$442.5K	50,000
2025-05-12	English Emily	Chief Operations Officer	Exercice d'Options (Vente)	7,500	$3.30	$24.75K	34,369
2025-04-15	English Emily	Chief Operations Officer	Exercice d'Options (Vente)	7,500	$3.30	$24.75K	41,869
2025-04-11	Springer Timothy A	10 Percent Owner	Achat Informatif	36,338	$10.77	$391.45K	656,513
2025-04-10	Springer Timothy A	10 Percent Owner	Achat Informatif	45,144	$10.43	$471.06K	616,724
2025-04-09	Springer Timothy A	10 Percent Owner	Achat Informatif	41,604	$9.43	$392.18K	571,402
2025-03-20	Springer Timothy A	10 Percent Owner	Achat Informatif	54,889	$15.59	$855.59K	8,621,325
2025-03-19	Springer Timothy A	10 Percent Owner	Achat Informatif	20,234	$14.97	$302.96K	8,566,436
2025-03-18	Springer Timothy A	10 Percent Owner	Achat Informatif	14,740	$14.42	$212.6K	8,546,202
2025-01-14	Springer Timothy A	10 Percent Owner	Achat Informatif	4,022	$18.00	$72.4K	8,531,462
2025-01-13	Springer Timothy A	10 Percent Owner	Achat Informatif	7,962	$16.86	$134.22K	8,518,457
2025-01-10	Jewell Christopher M	Chief Scientific Officer	Exercice d'Options	9,000	$3.23	$29.07K	62,490
2025-01-06	Brunn Carsten	President and CEO	Vente Informative	8,708	$16.83	$146.57K	204,096
2025-01-06	Davis Blaine	Chief Financial Officer	Vente Informative	4,028	$16.83	$67.8K	94,811
2025-01-06	Jewell Christopher M	Chief Scientific Officer	Vente Informative	1,286	$16.83	$21.65K	53,490
2025-01-06	Miljkovic Milos	Chief Medical Officer	Vente Informative	948	$16.83	$15.96K	35,393
2025-01-06	Kurtoglu Metin	Chief Technology Officer	Vente Informative	2,458	$16.83	$41.37K	62,258
2025-01-06	English Emily	Chief Operations Officer	Vente Informative	906	$16.83	$15.25K	40,226
2025-01-03	Brunn Carsten	President and CEO	Vente Informative	8,563	$16.72	$143.19K	212,804
2025-01-03	Davis Blaine	Chief Financial Officer	Vente Informative	3,961	$16.72	$66.24K	98,839
2025-01-03	Jewell Christopher M	Chief Scientific Officer	Vente Informative	1,264	$16.72	$21.14K	54,776
2025-01-03	Miljkovic Milos	Chief Medical Officer	Vente Informative	932	$16.72	$15.58K	36,341
2025-01-03	Kurtoglu Metin	Chief Technology Officer	Vente Informative	2,417	$16.72	$40.42K	64,716
2025-01-03	English Emily	Chief Operations Officer	Vente Informative	891	$16.72	$14.9K	41,132
2025-01-02	Springer Timothy A	10 Percent Owner	Attribution de RSU	7,800	$16.93	$132.05K	7,800

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration